[1]
|
Rudie, J.D., Rauschecker, A.M., Nabavizadeh, S.A. and Mohan, S. (2017) Neuroimaging of Dilated Perivascular Spaces: From Benign and Pathologic Causes to Mimics. Journal of Neuroimaging, 28, 139-149. https://doi.org/10.1111/jon.12493
|
[2]
|
Wardlaw, J.M., Smith, E.E., Biessels, G.J., Cordonnier, C., Fazekas, F., Frayne, R., et al. (2013) Neuroimaging Standards for Research into Small Vessel Disease and Its Contribution to Ageing and Neurodegeneration. The Lancet Neurology, 12, 822-838. https://doi.org/10.1016/s1474-4422(13)70124-8
|
[3]
|
Dubost, F., Yilmaz, P., Adams, H., Bortsova, G., Ikram, M.A., Niessen, W., et al. (2019) Enlarged Perivascular Spaces in Brain MRI: Automated Quantification in Four Regions. NeuroImage, 185, 534-544. https://doi.org/10.1016/j.neuroimage.2018.10.026
|
[4]
|
倪俊, 徐运. 脑小血管病转化医学研究中国专家共识[J]. 中国卒中杂志, 2018, 13(8): 853-870.
|
[5]
|
Iliff, J.J., Wang, M., Zeppenfeld, D.M., Venkataraman, A., Plog, B.A., Liao, Y., et al. (2013) Cerebral Arterial Pulsation Drives Paravascular CSF-Interstitial Fluid Exchange in the Murine Brain. The Journal of Neuroscience, 33, 18190-18199. https://doi.org/10.1523/jneurosci.1592-13.2013
|
[6]
|
Xie, L., Kang, H., Xu, Q., Chen, M.J., Liao, Y., Thiyagarajan, M., et al. (2013) Sleep Drives Metabolite Clearance from the Adult Brain. Science, 342, 373-377. https://doi.org/10.1126/science.1241224
|
[7]
|
Mestre, H., Kostrikov, S., Mehta, R.I. and Nedergaard, M. (2017) Perivascular Spaces, Glymphatic Dysfunction, and Small Vessel Disease. Clinical Science, 131, 2257-2274. https://doi.org/10.1042/cs20160381
|
[8]
|
Passiak, B.S., Liu, D., Kresge, H.A., Cambronero, F.E., Pechman, K.R., Osborn, K.E., et al. (2019) Perivascular Spaces Contribute to Cognition Beyond Other Small Vessel Disease Markers. Neurology, 92, e1309-e1321. https://doi.org/10.1212/wnl.0000000000007124
|
[9]
|
中国防治认知功能障碍专家共识专家组. 中国防治认知功能障碍专家共识[J]. 中华内科杂志, 2006, 45(2): 171-173.
|
[10]
|
钟晓南, 胡学强. 多发性硬化的研究进展[J]. 中华神经科杂志, 2014, 12(47): 886-887.
|
[11]
|
Kilsdonk, I., Steenwijk, M., Pouwels, P., Zwanenburg, J., Visser, F., Luijten, P., et al. (2014) Perivascular Spaces in MS Patients at 7 Tesla MRI: A Marker of Neurodegeneration? Multiple Sclerosis Journal, 21, 155-162. https://doi.org/10.1177/1352458514540358
|
[12]
|
Nation, D.A., Sweeney, M.D., Montagne, A., Sagare, A.P., D’Orazio, L.M., Pachicano, M., et al. (2019) Blood-Brain Barrier Breakdown Is an Early Biomarker of Human Cognitive Dysfunction. Nature Medicine, 25, 270-276. https://doi.org/10.1038/s41591-018-0297-y
|
[13]
|
Wardlaw, J.M., Doubal, F., Armitage, P., Chappell, F., Carpenter, T., Muñoz Maniega, S., et al. (2009) Lacunar Stroke Is Associated with Diffuse Blood-Brain Barrier Dysfunction. Annals of Neurology, 65, 194-202. https://doi.org/10.1002/ana.21549
|
[14]
|
Wingerchuk, D.M., Lennon, V.A., Pittock, S.J., Lucchinetti, C.F. and Weinshenker, B.G. (2006) Revised Diagnostic Criteria for Neuromyelitis Optica. Neurology, 66, 1485-1489. https://doi.org/10.1212/01.wnl.0000216139.44259.74
|
[15]
|
Mestre, H., Hablitz, L.M., Xavier, A.L., et al. (2018) Aquaporin-4-Dependent Glymphatic Solute Transport in the Rodent Brain. eLife, 7, e40070.
|
[16]
|
Filiano, A.J., Gadani, S.P. and Kipnis, J. (2017) How and Why Do T Cells and Their Derived Cytokines Affect the Injured and Healthy Brain? Nature Reviews Neuroscience, 18, 375-384. https://doi.org/10.1038/nrn.2017.39
|
[17]
|
Dehay, B., Bourdenx, M., Gorry, P., Przedborski, S., Vila, M., Hunot, S., et al. (2015) Targeting α-Synuclein for Treatment of Parkinson’s Disease: Mechanistic and Therapeutic Considerations. The Lancet Neurology, 14, 855-866. https://doi.org/10.1016/s1474-4422(15)00006-x
|
[18]
|
Blandini, F. (2013) Neural and Immune Mechanisms in the Pathogenesis of Parkinson’s Disease. Journal of Neuroimmune Pharmacology, 8, 189-201. https://doi.org/10.1007/s11481-013-9435-y
|
[19]
|
Xu, J., Fu, X., Pan, M., Zhou, X., Chen, Z., Wang, D., et al. (2019) Mitochondrial Creatine Kinase Is Decreased in the Serum of Idiopathic Parkinson’s Disease Patients. Aging and Disease, 10, 601-610. https://doi.org/10.14336/ad.2018.0615
|
[20]
|
Yang, W., Chang, Z., Que, R., Weng, G., Deng, B., Wang, T., et al. (2020) Contra-Directional Expression of Plasma Superoxide Dismutase with Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein as Important Markers of Parkinson’s Disease Severity. Frontiers in Aging Neuroscience, 12, Article 53. https://doi.org/10.3389/fnagi.2020.00053
|
[21]
|
梁源, 杨慧. 线粒体、α-突触核蛋白在帕金森病发病机制中的作用[J]. 中国临床康复, 2005, 9(9): 148-150.
|
[22]
|
张森, 赵晓悦, 梁宇, 等. 帕金森病致病因素及发病机制研究进展[J]. 药学学报, 2020, 55(10): 2264-2272.
|
[23]
|
Panicker, N., Sarkar, S., Harischandra, D.S., Neal, M., Kam, T., Jin, H., et al. (2019) Fyn Kinase Regulates Misfolded α-Synuclein Uptake and NLRP3 Inflammasome Activation in Microglia. Journal of Experimental Medicine, 216, 1411-1430. https://doi.org/10.1084/jem.20182191
|
[24]
|
Wang, T., Yuan, F., Chen, Z., Zhu, S., Chang, Z., Yang, W., et al. (2020) Vascular, Inflammatory and Metabolic Risk Factors in Relation to Dementia in Parkinson’s Disease Patients with Type 2 Diabetes Mellitus. Aging, 12, 15682-15704. https://doi.org/10.18632/aging.103776
|
[25]
|
Zheng, W., He, R., Yan, Z., Huang, Y., Huang, W., Cai, Z., et al. (2020) Regulation of Immune-Driven Pathogenesis in Parkinson’s Disease by Gut Microbiota. Brain, Behavior, and Immunity, 87, 890-897. https://doi.org/10.1016/j.bbi.2020.01.009
|